inhibitor of antibiotic resistance mechanism dexrazoxane ARO:3007736 ChEBI:50223 ChEMBL:CHEMBL1738 CAS:24584-09-6 antibiotic_resistance PubChem:71384 Dexrazoxane is a medication used in the management and treatment of anthracycline-induced cardiotoxicity and extravasation injuries. It was demonstrated to inhibit all tested metallo-beta-lactamases and showed an in vitro synergistic bactericidal effect with meropenem against metallo-beta-lactamases-producing bacteria. Dexrazoxane is a metal ion chelating agent.